ASX Announcement 21 October 2026 Update on Commercial Terms for the Proposed Merger with Microba Life Sciences • Genetic Signatures Limited (ASX: GSS) (GSS) and Microba Life Sciences Limited (ASX: MAP) (Microba) have agreed, in principle, to revised terms for the proposed merger, under which...
Update on Commercial Terms for Proposed Merger with MAP
Filed with ASX ·
Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings Call6ix is reading this filing.
Microba Life Sciences Limited on 6ix
Story so far
Earlier from Microba Life Sciences
- Q1 FY27 Quarterly Activities Report & Appendix 4C
- Microba secures $2m placement and increases cost reductions
- Appointment of Interim Chief Executive Officer
- GSS and MAP agree to Commercial Terms for Merger
- 2026 Annual Report & Appendix 4E
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences